Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

AtriCure (ATRC) EBIAT (2016 - 2025)

AtriCure (ATRC) has disclosed EBIAT for 16 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly EBIAT rose 111.28% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$11.4 million through Dec 2025, up 74.39% year-over-year, with the annual reading at -$11.4 million for FY2025, 74.39% up from the prior year.
  • EBIAT for Q4 2025 was $1.8 million at AtriCure, up from -$267000.0 in the prior quarter.
  • The five-year high for EBIAT was $97.1 million in Q3 2021, with the low at -$16.9 million in Q1 2021.
  • Average EBIAT over 5 years is -$4.1 million, with a median of -$8.5 million recorded in 2023.
  • The sharpest move saw EBIAT soared 2062.17% in 2021, then plummeted 134.75% in 2023.
  • Over 5 years, EBIAT stood at -$13.7 million in 2021, then skyrocketed by 69.65% to -$4.2 million in 2022, then tumbled by 134.75% to -$9.8 million in 2023, then plummeted by 59.04% to -$15.6 million in 2024, then soared by 111.28% to $1.8 million in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at $1.8 million, -$267000.0, and -$6.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.